These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25519982)

  • 1. A mechanistic investigation on the utilization of lactose as a protective agent for multi-unit pellet systems.
    Chin WC; Chan LW; Heng PW
    Pharm Dev Technol; 2016 Mar; 21(2):222-30. PubMed ID: 25519982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and process strategies to minimize coat damage for compaction of coated pellets in a rotary tablet press: A mechanistic view.
    Xu M; Heng PWS; Liew CV
    Int J Pharm; 2016 Feb; 499(1-2):29-37. PubMed ID: 26748363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of starting material particle size on pellet surface roughness.
    Sarkar S; Ang BH; Liew CV
    AAPS PharmSciTech; 2014 Feb; 15(1):131-9. PubMed ID: 24198222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of microcrystalline cellulose attributes affecting compaction-induced pellet coat damage through a multi-faceted analysis.
    Thio DR; Aguilera Q; Yeoh JKX; Sia Heng PW; Chan LW
    Int J Pharm; 2023 Aug; 643():123245. PubMed ID: 37467819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the coat quality of sustained release pellets by individual pellet dissolution methodology.
    Xu M; Liew CV; Heng PWS
    Int J Pharm; 2015 Jan; 478(1):318-327. PubMed ID: 25435182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mechanistic understanding of compression damage to the dissolubility of coated pellets in tablets.
    Hiew TN; Tian YH; Tan HM; Heng PWS
    Eur J Pharm Biopharm; 2020 Jan; 146():93-100. PubMed ID: 31786321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of sustained release matrix pellets by melt agglomeration in the fluidized bed: influence of formulation variables and modelling of agglomerate growth.
    Pauli-Bruns A; Knop K; Lippold BC
    Eur J Pharm Biopharm; 2010 Mar; 74(3):503-12. PubMed ID: 20026401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct compression of cushion-layered ethyl cellulose-coated extended release pellets into rapidly disintegrating tablets without changes in the release profile.
    Hosseini A; Körber M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):503-9. PubMed ID: 23892153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tableting of coated multiparticulates: Influences of punch face configurations.
    Thio DR; Veronica N; Heng PWS; Chan LW
    Int J Pharm; 2024 Mar; 653():123863. PubMed ID: 38307400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY; Yap HN; Chaw CS
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of mechanical properties of pellet containing tablets by thermal treatment.
    Csobán Z; Kállai-Szabó B; Kállai-Szabó N; Sebe I; Gordon P; Antal I
    Int J Pharm; 2015 Dec; 496(2):489-96. PubMed ID: 26475969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immobilization of fine particles on lactose carrier by precision coating and its effect on the performance of dry powder formulations.
    Chan LW; Lim LT; Heng PW
    J Pharm Sci; 2003 May; 92(5):975-84. PubMed ID: 12712417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlations between micromeritic properties of mixing powders of danshen extract and formability of their pellets].
    Xtong ZW; Luo Y; Liao ZG; Zhao GW; Li Z; Luo J
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4317-23. PubMed ID: 25850259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a novel dry-coated tablet technology for pellets as a substitute for the conventional encapsulation technology.
    Ando M; Kojima S; Ozeki Y; Nakayama Y; Nabeshima T
    Int J Pharm; 2007 May; 336(1):99-107. PubMed ID: 17223295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUPS Tableting-Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets.
    Thio DR; Heng PWS; Chan LW
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suspension pellet layering using PVA-PEG graft copolymer as a new binder.
    Suhrenbrock L; Radtke G; Knop K; Kleinebudde P
    Int J Pharm; 2011 Jun; 412(1-2):28-36. PubMed ID: 21497187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation and functionality of inhalation anhydrous lactose.
    Pitchayajittipong C; Price R; Shur J; Kaerger JS; Edge S
    Int J Pharm; 2010 May; 390(2):134-41. PubMed ID: 20100552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.